Accessing Biomedical Research Funding in Michigan's Aging Population
GrantID: 13693
Grant Funding Amount Low: $1,500,000
Deadline: June 30, 2025
Grant Amount High: $1,500,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Grant Overview
Michigan's Priority Outcomes for Biomedical Research Infrastructure Grants: Enhancing Research Excellence and Economic Growth in the State's Distressed Regions. Michigan, with its rich history of biomedical innovation and research, is poised to leverage the Banking Institution's Grant to Centers of Biomedical Research to establish a thematic, multi-disciplinary center that strengthens the state's research infrastructure. The Michigan biomedical research ecosystem is characterized by a strong presence of research institutions, including the University of Michigan, Michigan State University, and Wayne State University, which are supported by state agencies such as the Michigan Economic Development Corporation (MEDC) and the Michigan Department of Technology, Management, and Budget. A key geographic feature distinguishing Michigan is its economically distressed regions, particularly in the Upper Peninsula and rural areas, which face significant healthcare disparities and limited access to research funding. The priority outcomes for Michigan under this grant program are centered around enhancing research excellence, promoting economic development, and improving health outcomes in these underserved regions. To achieve these outcomes, the state will focus on establishing research centers of excellence that bring together interdisciplinary teams to tackle pressing biomedical challenges. By investing in research infrastructure and talent development, Michigan aims to increase its competitiveness for independent research funding, drive innovation, and create high-paying jobs in the biomedical sector. The state's priority outcomes are closely aligned with the MEDC's initiatives to revitalize regional economies and improve the overall quality of life for Michigan residents. Furthermore, the grant will support the development of small businesses and entrepreneurship in the biomedical sector, particularly in regions with limited access to capital, such as Detroit. By providing access to funding and resources, Michigan can foster a more vibrant and diverse research ecosystem, driving growth and innovation in the state's biomedical industry. In line with the state's goals, the grant will prioritize research projects that address specific health disparities and needs in Michigan, such as the high rates of cardiovascular disease and diabetes in the state's rural and minority populations. The University of Michigan's Michigan Institute for Clinical and Health Research (MICHR) is an example of an existing initiative that could be leveraged to support these efforts. By focusing on these priority outcomes, Michigan can maximize the impact of the grant funding and create a lasting legacy of research excellence and economic growth. The state's ability to achieve these outcomes will be supported by the MEDC's existing grant management infrastructure, which has successfully administered various grant programs, including the Michigan Small Business Development Center Network, providing free business consulting and low-cost training to small business owners. For Michigan applicants, understanding the priority outcomes and aligning their proposals accordingly will be crucial to securing funding. As the state continues to invest in its research infrastructure and talent development, the potential for growth and innovation in the biomedical sector is significant. By targeting specific areas of need and leveraging existing resources and infrastructure, Michigan can drive meaningful change and improve the health and well-being of its residents. Q: What are the key priority outcomes for Michigan under the Grant to Centers of Biomedical Research? A: The key priority outcomes for Michigan include enhancing research excellence, promoting economic development, and improving health outcomes in the state's distressed regions. Q: How will the grant funding be used to support small businesses and entrepreneurship in Michigan? A: The grant funding will be used to provide access to funding and resources for small businesses and entrepreneurs in the biomedical sector, particularly in regions with limited access to capital. Q: What specific health disparities is Michigan targeting with the grant funding? A: Michigan is targeting health disparities such as high rates of cardiovascular disease and diabetes in the state's rural and minority populations.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant to Support Research on Heart, Lung and Blood Diseases
Grant to support collaborative research efforts that investigate complex biomedical themes or resear...
TGP Grant ID:
60801
Mini-Grants for Supporting American Artists and Cultural Growth
A grant opportunity is available for individual artists and art groups based in New York or internat...
TGP Grant ID:
71583
U.S. Research Grants Advancing Health Innovation
This funding opportunity supports collaborative projects that aim to move promising research toward...
TGP Grant ID:
1861
Grant to Support Research on Heart, Lung and Blood Diseases
Deadline :
2026-09-25
Funding Amount:
$0
Grant to support collaborative research efforts that investigate complex biomedical themes or research questions related to fundamental processes and...
TGP Grant ID:
60801
Mini-Grants for Supporting American Artists and Cultural Growth
Deadline :
Ongoing
Funding Amount:
$0
A grant opportunity is available for individual artists and art groups based in New York or internationally, depending on the specific program. The fu...
TGP Grant ID:
71583
U.S. Research Grants Advancing Health Innovation
Deadline :
Ongoing
Funding Amount:
Open
This funding opportunity supports collaborative projects that aim to move promising research toward practical health solutions. It is generally availa...
TGP Grant ID:
1861